Market Cap (In USD)
269.58 Million
Revenue (In USD)
16.68 Million
Net Income (In USD)
-8.48 Million
Avg. Volume
30.43 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.41-28.257
- PE
- -
- EPS
- -
- Beta Value
- 1.777
- ISIN
- US0906842002
- CUSIP
- -
- CIK
- 1658678
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jason V. Matuszewski
- Employee Count
- -
- Website
- https://www.biostemtechnologies.com
- Ipo Date
- 2015-03-17
- Details
- BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
More Stocks
-
PLAZACABLEPlaza Wires Limited
PLAZACABLE
-
300855Jiangsu ToLand Alloy Co.,Ltd
300855
-
300886Anhui Hyea Aromas Co., Ltd.
300886
-
3172Tea Life Co., Ltd.
3172
-
8908
-
605258
-
OCCINOFS Credit Company, Inc.
OCCIN
-
7606United Arrows Ltd.
7606